Drug-Loaded Mesoporous Tantalum Oxide Nanoparticles for Enhanced Synergetic Chemoradiotherapy with Reduced Systemic Toxicity-Reference-Cited by-同舟云学术

Drug-Loaded Mesoporous Tantalum Oxide Nanoparticles for Enhanced Synergetic Chemoradiotherapy with Reduced Systemic Toxicity

Published:2016-12-13 Issue:8 Volume:13 Page:1602869
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Chen Yuyan¹,Song Guosheng¹,Dong Ziliang¹,Yi Xuan²,Chao Yu¹,Liang Chao¹,Yang Kai²,Cheng Liang¹,Liu Zhuang¹

Affiliation:

1. Institute of Functional Nano and Soft Materials (FUNSOM); Collaborative Innovation Center of Suzhou Nano Science and Technology, the Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices; Soochow University; Suzhou Jiangsu 215123 China

2. School of Radiation Medicine and Protection and School for Radiological and Interdisciplinary Sciences (RAD-X); Medical College of Soochow University; Suzhou Jiangsu 215123 China

Funder

National Natural Science Foundation of China

Juangsu Natural Science Fund for Distinguished Young Scholars

Collaborative Innovation Center of Suzhou Nano Science and Technology

Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Reference50 articles.

1. Breast cancer in China

2. Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial